Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

First Page		Document Content
Date: 2015-04-01 04:38:50 Multiple sclerosis Medicine Immunology Clinical medicine Autoimmune diseases Neurological disorders Neurology Management of multiple sclerosis Glatiramer acetate Immunosuppressants McDonald criteria Diagnostic criteria for MS		Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2 Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 240,99 KB Share Document on Facebook

	Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2 DocID: 1rmwo - View Document
	PDF Document DocID: 1rhTx - View Document
	PDF Document DocID: 1ptj0 - View Document
	PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION Pr COPAXONE® Glatiramer acetate DocID: 1kIzm - View Document
	Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators DocID: 1fWCE - View Document